ID   MRCKA_HUMAN             Reviewed;        1754 AA.
AC   Q5VT25-2;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   12-OCT-2022, entry version 169.
DE   RecName: Full=Isoform 2 of Serine/threonine-protein kinase MRCK alpha;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:29162624};
DE   AltName: Full=CDC42-binding protein kinase alpha;
DE   AltName: Full=DMPK-like alpha;
DE   AltName: Full=Myotonic dystrophy kinase-related CDC42-binding kinase alpha;
DE            Short=MRCK alpha;
DE            Short=Myotonic dystrophy protein kinase-like alpha;
GN   Name=CDC42BPA {ECO:0000312|EMBL:CAH71336.1}; Synonyms=KIAA0451;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAD57746.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 5), AND FUNCTION.
RC   TISSUE=Colon {ECO:0000312|EMBL:CAD57746.1};
RX   PubMed=15723050; DOI=10.1038/ncb1230;
RA   Wilkinson S., Paterson H.F., Marshall C.J.;
RT   "Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and
RT   cell invasion.";
RL   Nat. Cell Biol. 7:255-261(2005).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CAD57745.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANT VAL-1712.
RC   TISSUE=Brain {ECO:0000312|EMBL:CAD57745.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS ILE-1317
RP   AND VAL-1712.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAB37126.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-496, FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Mammary gland {ECO:0000269|PubMed:9092543};
RX   PubMed=9092543; DOI=10.1074/jbc.272.15.10013;
RA   Zhao Y., Loyer P., Li H., Valentine V., Kidd V., Kraft A.S.;
RT   "Cloning and chromosomal location of a novel member of the myotonic
RT   dystrophy family of protein kinases.";
RL   J. Biol. Chem. 272:10013-10020(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 799-1732 (ISOFORM 6), AND VARIANT
RP   VAL-1712.
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries from
RT   human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [7] {ECO:0000305, ECO:0000312|EMBL:CAD57745.1}
RP   SEQUENCE REVISION.
RA   Ohara O.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1521-1644, FUNCTION, INTERACTION WITH CDC42,
RP   AND MUTAGENESIS OF HIS-1579 AND HIS-1582.
RC   TISSUE=Brain {ECO:0000269|PubMed:9418861};
RX   PubMed=9418861; DOI=10.1128/mcb.18.1.130;
RA   Leung T., Chen X.-Q., Tan I., Manser E., Lim L.;
RT   "Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42
RT   effector in promoting cytoskeletal reorganization.";
RL   Mol. Cell. Biol. 18:130-140(1998).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF PPP1R12C.
RX   PubMed=11399775; DOI=10.1074/jbc.m102615200;
RA   Tan I., Ng C.H., Lim L., Leung T.;
RT   "Phosphorylation of a novel myosin binding subunit of protein phosphatase 1
RT   reveals a conserved mechanism in the regulation of actin cytoskeleton.";
RL   J. Biol. Chem. 276:21209-21216(2001).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF LIMK1 AND LIMK2.
RX   PubMed=11340065; DOI=10.1074/jbc.c100196200;
RA   Sumi T., Matsumoto K., Shibuya A., Nakamura T.;
RT   "Activation of LIM kinases by myotonic dystrophy kinase-related Cdc42-
RT   binding kinase alpha.";
RL   J. Biol. Chem. 276:23092-23096(2001).
RN   [11] {ECO:0000305}
RP   ACTIVITY REGULATION, OLIGOMERIZATION, PHOSPHORYLATION AT SER-222; SER-234
RP   AND THR-240, AND MUTAGENESIS OF LYS-106; SER-222; SER-234; THR-240 AND
RP   THR-403.
RX   PubMed=11283256; DOI=10.1128/mcb.21.8.2767-2778.2001;
RA   Tan I., Seow K.T., Lim L., Leung T.;
RT   "Intermolecular and intramolecular interactions regulate catalytic activity
RT   of myotonic dystrophy kinase-related Cdc42-binding kinase alpha.";
RL   Mol. Cell. Biol. 21:2767-2778(2001).
RN   [12]
RP   ALTERNATIVE SPLICING.
RX   PubMed=12568720; DOI=10.1016/s0378-1119(02)01185-x;
RA   Tan I., Cheong A., Lim L., Leung T.;
RT   "Genomic organization of human myotonic dystrophy kinase-related Cdc42-
RT   binding kinase alpha reveals multiple alternative splicing and functional
RT   diversity.";
RL   Gene 304:107-115(2003).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH LURAP1 AND MYO18A.
RX   PubMed=18854160; DOI=10.1016/j.cell.2008.09.018;
RA   Tan I., Yong J., Dong J.M., Lim L., Leung T.;
RT   "A tripartite complex containing MRCK modulates lamellar actomyosin
RT   retrograde flow.";
RL   Cell 135:123-136(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1545; SER-1719 AND SER-1721,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=20188707; DOI=10.1016/j.bbrc.2010.02.148;
RA   Cmejla R., Ptackova P., Petrak J., Savvulidi F., Cerny J., Sebesta O.,
RA   Vyoral D.;
RT   "Human MRCKalpha is regulated by cellular iron levels and interferes with
RT   transferrin iron uptake.";
RL   Biochem. Biophys. Res. Commun. 395:163-167(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   FUNCTION IN PHOSPHORYLATION OF PPP1R12A AND MYL9/MLC2, AND ACTIVITY
RP   REGULATION.
RX   PubMed=21457715; DOI=10.1016/j.febslet.2011.03.054;
RA   Tan I., Lai J., Yong J., Li S.F., Leung T.;
RT   "Chelerythrine perturbs lamellar actomyosin filaments by selective
RT   inhibition of myotonic dystrophy kinase-related Cdc42-binding kinase.";
RL   FEBS Lett. 585:1260-1268(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1651, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1611; SER-1613; SER-1629;
RP   SER-1651; SER-1664 AND SER-1721, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1669 AND SER-1693, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   FUNCTION, CATALYTIC ACTIVITY, PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF
RP   ASP-478 AND ASP-984.
RX   PubMed=29162624; DOI=10.1083/jcb.201703044;
RA   Gagliardi P.A., Somale D., Puliafito A., Chiaverina G., di Blasio L.,
RA   Oneto M., Bianchini P., Bussolino F., Primo L.;
RT   "MRCKalpha is activated by caspase cleavage to assemble an apical actin
RT   ring for epithelial cell extrusion.";
RL   J. Cell Biol. 217:231-249(2018).
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-50; MET-231; THR-537; MET-780; CYS-790;
RP   THR-1148; HIS-1211; ILE-1317; LYS-1418; VAL-1469 AND ALA-1618.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist. They arise due to a two
CC         alternate splice sites, the first site involves splicing of exons 21-
CC         24 while the second site involves exons 36-40.;
CC       Name=1 {ECO:0000305};
CC         IsoId=Q5VT25-1; Sequence=Displayed;
CC       Name=2 {ECO:0000305};
CC         IsoId=Q5VT25-2; Sequence=VSP_051861, VSP_051863;
CC       Name=3 {ECO:0000269|PubMed:15723050};
CC         IsoId=Q5VT25-3; Sequence=VSP_051859, VSP_051860;
CC       Name=4 {ECO:0000269|PubMed:16710414};
CC         IsoId=Q5VT25-4; Sequence=VSP_051862;
CC       Name=5 {ECO:0000269|PubMed:15723050};
CC         IsoId=Q5VT25-5; Sequence=VSP_051860;
CC       Name=6;
CC         IsoId=Q5VT25-6; Sequence=VSP_051860, VSP_035286;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   RefSeq; XP_005273379.1; XM_005273322.3.
DR   ProteomicsDB; 65292; -.
DR   Ensembl; ENST00000366766.8; ENSP00000355728.5; ENSG00000143776.20.
DR   MANE-Select; ENST00000366766.8; ENSP00000355728.5; NM_001394014.1; NP_001380943.1.
DR   Proteomes; UP000005640; Chromosome 1.
PE   1: Evidence at protein level;
SQ   SEQUENCE   1754 AA;  199811 MW;  F1CC5CC1ED23B388 CRC64;
     MSGEVRLRQL EQFILDGPAQ TNGQCFSVET LLDILICLYD ECNNSPLRRE KNILEYLEWA
     KPFTSKVKQM RLHREDFEIL KVIGRGAFGE VAVVKLKNAD KVFAMKILNK WEMLKRAETA
     CFREERDVLV NGDNKWITTL HYAFQDDNNL YLVMDYYVGG DLLTLLSKFE DRLPEDMARF
     YLAEMVIAID SVHQLHYVHR DIKPDNILMD MNGHIRLADF GSCLKLMEDG TVQSSVAVGT
     PDYISPEILQ AMEDGKGRYG PECDWWSLGV CMYEMLYGET PFYAESLVET YGKIMNHKER
     FQFPAQVTDV SENAKDLIRR LICSREHRLG QNGIEDFKKH PFFSGIDWDN IRNCEAPYIP
     EVSSPTDTSN FDVDDDCLKN SETMPPPTHT AFSGHHLPFV GFTYTSSCVL SDRSCLRVTA
     GPTSLDLDVN VQRTLDNNLA TEAYERRIKR LEQEKLELSR KLQESTQTVQ ALQYSTVDGP
     LTASKDLEIK NLKEEIEKLR KQVTESSHLE QQLEEANAVR QELDDAFRQI KAYEKQIKTL
     QQEREDLNKE LVQASERLKN QSKELKDAHC QRKLAMQEFM EINERLTELH TQKQKLARHV
     RDKEEEVDLV MQKVESLRQE LRRTERAKKE LEVHTEALAA EASKDRKLRE QSEHYSKQLE
     NELEGLKQKQ ISYSPGVCSI EHQQEITKLK TDLEKKSIFY EEELSKREGI HANEIKNLKK
     ELHDSEGQQL ALNKEIMILK DKLEKTRRES QSEREEFESE FKQQYEREKV LLTEENKKLT
     SELDKLTTLY ENLSIHNQQL EEEVKDLADK KESVAHWEAQ ITEIIQWVSD EKDARGYLQA
     LASKMTEELE ALRNSSLGTR ATDMPWKMRR FAKLDMSARL ELQSALDAEI RAKQAIQEEL
     NKVKASNIIT ECKLKDSEKK NLELLSEIEQ LIKDTEELRS EKGIEHQDSQ HSFLAFLNTP
     TDALDQFETD PVENTYVWNP SVKFHIQSRS TSPSTSSEAE PVKTVDSTPL SVHTPTLRKK
     GCPGSTGFPP KRKTHQFFVK SFTTPTKCHQ CTSLMVGLIR QGCSCEVCGF SCHITCVNKA
     PTTCPVPPEQ TKGPLGIDPQ KGIGTAYEGH VRIPKPAGVK KGWQRALAIV CDFKLFLYDI
     AEGKASQPSV VISQVIDMRD EEFSVSSVLA SDVIHASRKD IPCIFRVTAS QLSASNNKCS
     ILMLADTENE KNKWVGVLSE LHKILKKNKF RDRSVYVPKE AYDSTLPLIK TTQAAAIIDH
     ERIALGNEEG LFVVHVTKDE IIRVGDNKKI HQIELIPNDQ LVAVISGRNR HVRLFPMSAL
     DGRETDFYKL SETKGCQTVT SGKVRHGALT CLCVAMKRQV LCYELFQSKT RHRKFKEIQV
     PYNVQWMAIF SEQLCVGFQS GFLRYPLNGE GNPYSMLHSN DHTLSFIAHQ PMDAICAVEI
     SSKEYLLCFN SIGIYTDCQG RRSRQQELMW PANPSSCCYN APYLSVYSEN AVDIFDVNSM
     EWIQTLPLKK VRPLNNEGSL NLLGLETIRL IYFKNKMAEG DELVVPETSD NSRKQMVRNI
     NNKRRYSFRV PEEERMQQRR EMLRDPEMRN KLISNPTNFN HIAHMGPGDG IQILKDLPMN
     PRPQESRTVF SGSVSIPSIT KSRPEPGRSM SASSGLSARS SAQNGSALKR EFSGGSYSAK
     RQPMPSPSEG SLSSGGMDQG SDAPARDFDG EDSDSPRHST ASNSSNLSSP PSPASPRKTK
     SLSLESTDRG SWDP
//
